BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23183057)

  • 1. The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex.
    Amin S; Carter M; Edwards RJ; Pople I; Aquilina K; Merrifield J; Osborne JP; O'Callaghan FJ
    Eur J Paediatr Neurol; 2013 Jan; 17(1):36-44. PubMed ID: 23183057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
    Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
    Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex.
    Harter DH; Bassani L; Rodgers SD; Roth J; Devinsky O; Carlson C; Wisoff JH; Weiner HL
    J Neurosurg Pediatr; 2014 Jan; 13(1):21-8. PubMed ID: 24180681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gradual formation of an operative corridor by balloon dilation for resection of subependymal giant cell astrocytomas in children with tuberous sclerosis: specialized minimal access technique of balloon dilation.
    Levine NB; Collins J; Franz DN; Crone KR
    Minim Invasive Neurosurg; 2006 Oct; 49(5):317-20. PubMed ID: 17163349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct medical costs for patients with tuberous sclerosis complex and surgical resection of subependymal giant cell astrocytoma: a US national cohort study.
    Sun P; Liu Z; Krueger D; Kohrman M
    J Med Econ; 2015 May; 18(5):349-56. PubMed ID: 25525770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of resecting subependymal giant cell astrocytoma (SEGA) among patients with SEGA-related tuberous sclerosis complex: a national claims database analysis.
    Sun P; Kohrman M; Liu J; Guo A; Rogerio J; Krueger D
    Curr Med Res Opin; 2012 Apr; 28(4):657-63. PubMed ID: 22375958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
    Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
    Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subependymal giant cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients].
    Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; Carceller F; Hernández-Moneo JL; Gutiérrez-Molina M; Morales C
    Neurologia; 2010 Jun; 25(5):314-21. PubMed ID: 20643042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection of subependymal giant cell astrocytomas (SEGAs) and changes in SEGA-related conditions: a US national claims database study.
    Sun P; Krueger D; Liu J; Guo A; Rogerio J; Kohrman M
    Curr Med Res Opin; 2012 Apr; 28(4):651-6. PubMed ID: 22375957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex.
    Fohlen M; Ferrand-Sorbets S; Delalande O; Dorfmüller G
    Childs Nerv Syst; 2018 Aug; 34(8):1511-1519. PubMed ID: 29766265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.
    Giordano F; Moscheo C; Lenge M; Biagiotti R; Mari F; Sardi I; Buccoliero AM; Mongardi L; Aronica E; Guerrini R; Genitori L
    Childs Nerv Syst; 2020 May; 36(5):951-960. PubMed ID: 31853898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
    Cardamone M; Flanagan D; Mowat D; Kennedy SE; Chopra M; Lawson JA
    J Pediatr; 2014 May; 164(5):1195-200. PubMed ID: 24518170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
    Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
    Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H
    BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurosurgical aspects in the treatment of children with tuberous sclerosis complex].
    Roth J; Fried I; Constantini S
    Harefuah; 2014 Jan; 153(1):43-7, 63. PubMed ID: 24605407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
    Jóźwiak S; Nabbout R; Curatolo P;
    Eur J Paediatr Neurol; 2013 Jul; 17(4):348-52. PubMed ID: 23391693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U
    J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas.
    Bongaarts A; van Scheppingen J; Korotkov A; Mijnsbergen C; Anink JJ; Jansen FE; Spliet WGM; den Dunnen WFA; Gruber VE; Scholl T; Samueli S; Hainfellner JA; Feucht M; Kotulska K; Jozwiak S; Grajkowska W; Buccoliero AM; Caporalini C; Giordano F; Genitori L; Coras R; Blümcke I; Krsek P; Zamecnik J; Meijer L; Scicluna BP; Schouten-van Meeteren AYN; Mühlebner A; Mills JD; Aronica E
    Brain; 2020 Jan; 143(1):131-149. PubMed ID: 31834371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subependymal giant cell tumors in tuberous sclerosis complex.
    Goh S; Butler W; Thiele EA
    Neurology; 2004 Oct; 63(8):1457-61. PubMed ID: 15505165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic endoscopic resection and surgical management of a subependymal giant cell astrocytoma: case report.
    Rodgers SD; Bassani L; Weiner HL; Harter DH
    J Neurosurg Pediatr; 2012 Apr; 9(4):417-20. PubMed ID: 22462708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.